MMP-9 immunoreactivity in acute migraine

Headache

Volumn 47, Issue 5, 2007, Pages 698-702

  Leira, Rogelio ^a,b   Sobrino, Tomás ^a   Rodríguez Yáñez, Manuel ^a   Blanco, Miguel ^a   Arias, Susana ^a   Castillo, José ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Blood brain barrier; Inflammation; Metalloproteinase; Migraine

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ADULT; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 34248370099     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00641.x     Document Type: Article

References (18)

1. Olesen J, Goadsby P. Synthesis of migraine mechanisms. In : Olesen J, Goadsby P, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches. Philadelphia : Lippincott Williams and Wilkins 2006 : 393 398.
2. Alvarez-Cermeño J, Gobernado JM, Gimeno A. Transient blood-brain barrier (BBB) damage in migraine. Neurology. 1986 26 : 437.
3. Dreier JP, Jurkat-Rott K, Petzold GC, et al. Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II. Neurology. 2005 64 : 2145 2147.
4. Kaube H, Hoskin KL, Goadsby PJ. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol. 1993 109 : 788 792.
5. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet. 1990 121 125.
6. Chandler S, Miller KM, Clements JM, et al. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: An overview. J Neuroimmunol. 1997 72 : 155 161.
7. Leppert D, Waubant E, Galardy R, et al. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol. 1995 154 : 4397 4389.
8. Aoki T, Sumii T, Mori T, et al. Blood-brain barrier disruption and matrix-metalloproteinase-9 expression during reperfusion injury: Mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke. 2002 33 : 2711 2777.
9. Rosenberg GA, Cunningham LA, Wallace J, et al. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: Activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 2001 893 : 104 112.
10. Castellanos M, Leira R, Serena J, et al. Plasma metallloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke. 2003 34 : 40 46.
11. Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke. Stroke. 2001 32 : 2762 2767.
12. Heo JH, Lucero J, Abumiya T, et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab. 1999 19 : 624 633.
13. Rosenberg GA, Mun-Bryce S, Wesley M, et al. Collagenase-induced intracerebral hemorrhage in the rat. Stroke. 1990 21 : 801 807.
14. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004 113 : 1447 1455.
15. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004 suppl 1).
16. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981 9 : 344 352.
17. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994 117 : 199 210.
18. Hadjikhani N, Sánchez del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Nat Acad Sci USA. 2001 98 : 4687 4692.